Detalles de la búsqueda
1.
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine.
Cell
; 184(23): 5699-5714.e11, 2021 11 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34735795
2.
Unsupervised machine learning to investigate trajectory patterns of COVID-19 symptoms and physical activity measured via the MyHeart Counts App and smart devices.
NPJ Digit Med
; 6(1): 239, 2023 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38135699
3.
Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy.
iScience
; 26(7): 107056, 2023 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37346049
4.
Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens.
Med
; 4(3): 191-215.e9, 2023 03 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36863347
5.
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease.
Nat Med
; 29(7): 1760-1774, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37414897
6.
mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individuals.
Front Immunol
; 13: 953949, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36159846
7.
T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study.
Lancet Microbe
; 3(1): e21-e31, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34778853
8.
Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Cochrane Database Syst Rev
; (9): CD004610, 2011 Sep 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-21901692
Resultados
1 -
8
de 8
1
Próxima >
>>